Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues

BACKGROUND: Coronary artery disease leading to myocardial ischemia is the most common cause of heart failure. Apelin (APLN), the endogenous peptide ligand of the APJ receptor, has emerged as a novel regulator of the cardiovascular system. METHODS AND RESULTS: Here we show a critical role of APLN in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wang, Wang, McKinnie, Shaun M.K., Patel, Vaibhav B., Haddad, George, Wang, Zuocheng, Zhabyeyev, Pavel, Das, Subhash K., Basu, Ratnadeep, McLean, Brent, Kandalam, Vijay, Penninger, Josef M., Kassiri, Zamaneh, Vederas, John C., Murray, Allan G., Oudit, Gavin Y.
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828798/
https://ncbi.nlm.nih.gov/pubmed/23817469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000249
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars